Research / AXIL / Fundamental state Inspectable configuration
State dimensions Filing 0001520138-25-000299 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
2.03% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.12% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-10.78% · OPTIONAL · VALID
Revenue growth 35th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
17.17% · CORE · VALID
Inventory pressure 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
56.73% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
67.60% · CORE · VALID
Operating margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
6.01% · CORE · VALID
SBC intensity 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.91% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Aug 31, 2021 6/6 normalized Level 3 Nov 30, 2021 6/6 normalized Level 3 Feb 28, 2022 6/6 normalized Level 3 May 31, 2022 6/6 normalized Level 3 Aug 31, 2022 7/7 normalized Level 3 Nov 30, 2022 7/7 normalized Level 3 Feb 28, 2023 7/7 normalized Level 3 May 31, 2023 7/8 normalized Level 3 Aug 31, 2023 7/7 normalized Level 3 Nov 30, 2023 5/5 normalized Level 3 Feb 29, 2024 7/7 normalized Level 3 May 31, 2024 7/8 normalized Level 3 Aug 31, 2024 6/7 normalized Level 3 Nov 30, 2024 6/7 normalized Level 3 Feb 28, 2025 7/8 normalized Level 3 May 31, 2025 7/8 normalized Level 3 Aug 31, 2025 7/8 normalized Level 3 Nov 30, 2025 7/8 normalized Level 3 Feb 28, 2026 8/8 normalized Level 3 May 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 0.53%
Current 2.03%
Delta 1.50% Capex Intensity Decreased
Previous 0.81%
Current 0.12%
Delta -0.69% Cash Generation Decreased
Previous 7.35%
Current -10.78%
Delta -18.13% Growth Increased
Previous -4.51%
Current 17.17%
Delta 21.69% Inventory Pressure Increased
Previous 9.65%
Current 56.73%
Delta 47.08% Margin Decreased
Previous 71.00%
Current 67.60%
Delta -3.39% Profitability Increased
Previous 4.42%
Current 6.01%
Delta 1.58% Sbc Intensity Decreased
Previous 4.22%
Current 2.91%
Delta -1.32% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.